Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06039267 · ClinicalTrials.gov registry record
Brain Health & the Microbiome
A clinical trial, sponsored by George Washington University.
- Completed
- Registry status
- 44
- Enrollment target
NCT06039267: Completed study, sponsored by George Washington University.
NCT06039267 is a clinical trial that has completed, run by George Washington University. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06039267 has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
The GW SMHS supports research in complementary and integrative approaches to treatment of sickness and disease and for health promotion. Sometimes, research may involve asking questions of patients, students, and health providers. In this study, individuals are being asked to participate in this study as either 1) a healthy volunteer, 2) a person with Mild Cognitive Impairment (MCI), or 3) a person with early Alzheimer's disease (eAD). We are trying to learn more about if the gut microbiome (the microbes that live in our digestive tract) of individuals with eAD, MCI, and healthy controls are altered following lifestyle changes. This research will provide the pilot data to begin to understand if these changes in the gut microbiome are beneficial to health and/or may slow or halt the progression of MCI or early Alzheimer's.
Primary Outcome
To compare the gut microbiomes of patients with early Alzheimer's disease, mild cognitive impairment, and healthy controls using diversity as well as genus, species, and strain level differences in composition (shotgun metagenomics).
Interventions
- OTHER Gut Microbiome Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2023-08-25 |
| Est. Completion | 2025-08-24 |
What the finished NCT06039267 record still lists
NCT06039267 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Gut Microbiome Testing is the first listed.
NCT06039267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06039267 about?
NCT06039267 is a clinical study titled "Brain Health & the Microbiome". The GW SMHS supports research in complementary and integrative approaches to treatment of sickness and disease and for health promotion. Sometimes, research may involve asking questions of patients, students, and health providers. In this study, individuals are being asked to participate in this stu...
What is the current status of trial NCT06039267?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2023-08-25. Estimated completion is 2025-08-24.
What interventions are being tested in trial NCT06039267?
The interventions under investigation include: Gut Microbiome Testing (OTHER).
Who is sponsoring clinical trial NCT06039267?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI